drugset / Trial / NCT00626613

The Relationship Between Risperdal Treatment and Quality of Life in Patients With Alzheimer's Disease and Behavioural and Psychological Symptoms of Dementia (BPSD)

NCT00626613

NaSingle-groupDouble-blind

Summary

To evaluate the relationship between Risperidone Treatment, Treatment Discontinuation Rate, and Quality of Life of patients with Alzheimer's Disease and BPSD.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Risperidone Other / unclassified 2 ml Oral
Background Galantamine Small molecule 8 mg

Indications